Stock CALT CALLIDITAS THERAPEUTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Calliditas Therapeutics AB Nasdaq

Equities

CALT

US13124Q1067

Real-time Estimate Cboe BZX
Other stock markets
 10:35:00 2024-05-21 am EDT 		5-day change 1st Jan Change
21.78 USD -1.00% Intraday chart for Calliditas Therapeutics AB +4.66% -14.54%
May. 20 European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading MT
May. 16 European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading MT

Evolution of the average Target Price on Calliditas Therapeutics AB

Price target over the last 5 years

History of analyst recommendation changes

f.gB3w74yviyl5V7s7g-9AoC2RvFAEkGu6UXjjfv5_nt8.ymqZt9r6_kdBbvAC79sS4X-nzQIx4gjIKA6rS68U1rbSUIKXx-7PTS40gw~a2be75f04421b3582d0e5c0596286b31

Analyst Recommendations on Calliditas Therapeutics AB

Guggenheim Adjusts Calliditas Therapeutics' Price Target to $18 From $21, Keeps Neutral Rating MT
HC Wainwright Initiates Coverage on Calliditas Therapeutics With Buy Rating, $60 Price Target MT
Guggenheim Initiates Calliditas Therapeutics at Neutral With $18 Price Target MT
HC Wainwright Adjusts Calliditas Therapeutics' Price Target to $62 From $52, Reiterates Buy Rating MT
Citigroup Adjusts Calliditas Therapeutics' Price Target to $84 From $51, Reiterates Buy Rating MT
ANALYST RECOMMENDATIONS : Alibaba, Goldman Sachs, Monday.com, Shaftesbury, 3M Company... Our Logo
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
117.6 SEK
Average target price
208 SEK
Spread / Average Target
+76.87%
High Price Target
270 SEK
Spread / Highest target
+129.59%
Low Price Target
161 SEK
Spread / Lowest Target
+36.90%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Calliditas Therapeutics AB

Guggenheim
HC Wainwright
Citigroup

Ratings for Calliditas Therapeutics AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CALTX Stock
  4. CALT Stock
  5. Consensus Calliditas Therapeutics AB
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW